These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1781732)

  • 1. [The pharmacokinetics of antilipemic agents. 8. Unequivocal characterization of ciprofibrate-O-beta-d-glucuronide].
    Oelschläger H; Kohl C; Armstrong DW; Rothley D
    Arch Pharm (Weinheim); 1991 Aug; 324(8):505-8. PubMed ID: 1781732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmacokinetics of antilipemic agents. 5. Is 2-(4-hydroxyphenoxy)-2-methylpropionic acid a metabolite of the antilipemic ciprofibrate?].
    Oelschläger H; Rothley D; Hellwich KH; Schmidt W
    Arch Pharm (Weinheim); 1989 Jun; 322(6):337-42. PubMed ID: 2774869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conjugation reactions of ciprofibrate with human and laboratory animals].
    Oelschläger H; Müller D; Hellwich KH; Ueberall S; Seeling A; Machts H; Hofmann B; Glöckner R
    Arzneimittelforschung; 2003; 53(4):247-53. PubMed ID: 12785120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of UV-derivative spectra for determination of four antihyperlipidaemic drugs in pharmaceutical formulations.
    Komsta L; Misztal G
    Acta Pol Pharm; 2004; 61(1):9-13. PubMed ID: 15259852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of antilipemic agents. 4. Biotransformation of the antilipemic agent ciprofibrate (2-(4-(2,2-dichlorcyclopropyl)-phenoxy)-2-methylpropionic acid)].
    Oelschläger H; Rothley D; Schmidt W
    Arch Pharm (Weinheim); 1988 Jun; 321(6):367-70. PubMed ID: 3178437
    [No Abstract]   [Full Text] [Related]  

  • 6. High performance liquid chromatographic determination of etofibrate and its hydrolysis products.
    el-Gindy A; Hadad GM; Mahmoud WM
    J Pharm Biomed Anal; 2007 Jan; 43(1):196-203. PubMed ID: 16901673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofibrate--a profile.
    Betteridge DJ
    Postgrad Med J; 1993; 69 Suppl 1():S42-7; discussion S47-9. PubMed ID: 8497456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of fibrate-type antihyperlipidemic drugs by capillary electrophoresis and their quantitation in pharmaceuticals.
    Komsta Ł; Misztal G; Majchrzak E; Hauzer A
    J Pharm Biomed Anal; 2006 May; 41(2):408-14. PubMed ID: 16426791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of seven glucuronide conjugates of andrographolide in human urine.
    Cui L; Qiu F; Yao X
    Drug Metab Dispos; 2005 Apr; 33(4):555-62. PubMed ID: 15644451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacokinetics of hypolipemic agents. 10. The dehalogenation of the hypolipemic agent ciprofibrate].
    Oelschläger H; Hellwich KH; Rothley D
    Arch Pharm (Weinheim); 1994 Apr; 327(4):261-5. PubMed ID: 8204026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of [14C]clofibric acid glucuronide and [14C]clofibric acid in plasma and urine using high-performance liquid chromatography.
    Meffin PJ; Zilm DM
    J Chromatogr; 1983 Nov; 278(1):101-8. PubMed ID: 6662867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods of chromatographic determination of medicines decreasing the level of cholesterol.
    Kublin E; Kaczmarska-Graczyk B; Malanowicz E; Mazurek AP
    Acta Pol Pharm; 2010; 67(5):455-61. PubMed ID: 20873411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pharmacokinetics of hypolipemic agents. 6. Is 2-(4-(2,2-dichlorocyclopropyl)-phenoxy)-propane a metabolite of the hypolipemic ciprofibrate?].
    Oelschläger H; Rothley D; Hellwich KH; Schmidt W
    Arch Pharm (Weinheim); 1989 Oct; 322(10):629-32. PubMed ID: 2624522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate.
    Pacot C; Petit M; Rollin M; Behechti N; Moisant M; Deslex P; Althoff J; Lhuguenot JC; Latruffe N
    Arch Biochem Biophys; 1996 Mar; 327(1):181-8. PubMed ID: 8615689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and formation of the glutathione conjugate of clofibric acid.
    Shore LJ; Fenselau C; King AR; Dickinson RG
    Drug Metab Dispos; 1995 Jan; 23(1):119-23. PubMed ID: 7720514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achiral and chiral determination of ciprofibrate and its glucuronide in human urine by capillary electrophoresis.
    Hüttemann H; Blaschke G
    J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):33-41. PubMed ID: 10410925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites.
    Zenser TV; Lakshmi VM; Davis BB
    Drug Metab Dispos; 1999 Sep; 27(9):1064-7. PubMed ID: 10460807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization to eliminate the interference of migration isomers for measuring 1-O-beta-acyl glucuronide without extensive chromatographic separation.
    Xue YJ; Akinsanya JB; Raghavan N; Zhang D
    Rapid Commun Mass Spectrom; 2008; 22(2):109-20. PubMed ID: 18059002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo irreversible plasma protein binding of beclobric acid enantiomers.
    Mayer S; Mutschler E; Benet LZ; Sphahn-Langguth H
    Chirality; 1993; 5(3):120-5. PubMed ID: 8338721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.